The Role of Pharmacokinetics in the Development of Biotechnologically Derived Agents
- 1 December 1992
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 23 (6) , 406-414
- https://doi.org/10.2165/00003088-199223060-00002
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- A Decade of Development in Immunoassay MethodologyClinical Chemistry, 1990
- [51] Protein blotting and immunodetectionPublished by Elsevier ,1990
- Quantification of recombinant interleukin-2 in human serum by a specific immunobioassayAnalytical Chemistry, 1989
- Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.Journal of Clinical Investigation, 1986
- Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.Journal of Clinical Investigation, 1985
- PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGICAL-ACTIVITY OF RECOMBINANT GAMMA-INTERFERON IN CANCER-PATIENTS1985
- Effect of Desialylation of Human Chorionic Gonadotropin on Its Metabolic Clearance Rate in HumansJournal of Clinical Endocrinology & Metabolism, 1984
- Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injectionClinical Pharmacology & Therapeutics, 1984
- EFFECTS OF 3 RECOMBINANT HUMAN-LEUKOCYTE INTERFERONS ON DRUG-METABOLISM IN MICE1982
- Renal filtration, transport, and metabolism of low-molecular-weight proteins: A reviewKidney International, 1979